 Home > Medical News > Latest Medical News > China Securities Regulatory Commission terminates the issuance and registration of Bite Pharmaceuticals on the Growth Enterprise Market

China Securities Regulatory Commission terminates the issuance and registration of Bite Pharmaceuticals on the Growth Enterprise Market

 Last Update: 2022-03-09
 Source: Internet
 Author: User

Tags

fema online application

biologics license application

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On January 11, the China Securities Regulatory Commission issued an announcement stating that Better Pharmaceuticals and the sponsor Huatai United Securities Co.
, Ltd.
submitted the "Chengdu Better Pharmaceutical Co.
, Ltd.
on the withdrawal of the initial public offering and the Application for Listing Application Documents on the Growth Enterprise Market” (Xingbei Yaozi [2021] No.
475) and “Application for Withdrawing the Application Documents for the Initial Public Offering of Shares by Chengdu Better Pharmaceutical Co.
, Ltd.
and Listing on the Growth Enterprise Market” (Huatai Lianhezi [2021] No.
571), voluntarily requested to withdraw the registration application documents
.

In accordance with Article 30 of the Administrative Measures for the Registration of Initial Public Offerings on the Growth Enterprise Market (for Trial Implementation), the China Securities Regulatory Commission has decided to terminate its offering registration procedures
.

According to the prospectus, Better Pharmaceuticals is mainly engaged in the research and development, production and sales of high-end generic drugs, innovative drugs and APIs
.

During the reporting period, there were more than 140 product specifications on sale, covering multiple segments such as anti-infection, reproductive system, cardiovascular system, blood and hematopoietic system

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.